- Home
- RVP vs NCEL Comparison
RVP vs NCEL Comparison
Compare RVP & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVP | NCEL |
|---|---|---|
| Founded | 1994 | 2008 |
| Country | United States | Switzerland |
| Employees | N/A | 4 |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 20.6M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | RVP | NCEL |
|---|---|---|
| Price | $0.69 | $3.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 52.3K | ★ 71.2K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $38,266,211.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.78 | N/A |
| 52 Week Low | $0.60 | $1.83 |
| 52 Week High | $1.14 | $5.12 |
Technical Indicators
Market Signals| Indicator | RVP | NCEL |
|---|---|---|
| Relative Strength Index (RSI) | 50.95 | 45.40 |
| Support Level | $0.62 | $2.50 |
| Resistance Level | $0.74 | $3.16 |
| Average True Range (ATR) | 0.05 | 0.39 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 49.32 | 0.56 |
Price Performance
Historical ComparisonAbout RVP Retractable Technologies Inc.
Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.
About NCEL NewcelX Ltd. Ordinary Shares
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.